CdS/g-C3N4 core/shell nanowires with different g-C3N4 contents were fabricated by a combined solvothermal and chemisorption method and characterized by X-ray powder diffraction, scanning electronic microscopy, transmission electron microscopy, and UV-vis diffuse reflection spectroscopy. The photocatalytic hydrogen-production activities of these samples were evaluated using Na2S and Na2SO3 as sacrificial reagents in water under visible-light illumination (λ≥420 nm). The results show that after a spontaneous adsorption process g-C3N4 is successfully coated on CdS nanowires with intimate contact and can significantly improve the photocatalytic hydrogen-production rate of CdS nanowires, which reaches an optimal value of up to 4152 μmol h(-1) g(-1) at the g-C3N4 content of 2 wt %. More importantly, g-C3N4 coating can substantially reinforce the photostability of CdS nanowires even in a nonsacrificial system. The synergic effect between g-C3N4 and CdS, which can effectively accelerate the charge separation and transfer corrosive holes from CdS to robust C3N4, was proposed to be responsible for the enhancement of the photocatalytic activity and photostability. The possible conditions necessary for the synergic effect to work in a CdS/g-C3N4 core/shell configuration is also discussed.

Abstract:The Wnt signaling pathway plays an important role not only in embryonic development but also in the maintenance and differentiation of the stem cells in adulthood. In particular, Wnt signaling has been shown as an important regulatory pathway in the osteogenic differentiation of mesenchymal stem cells. Induction of the Wnt signaling pathway promotes bone formation while inactivation of the pathway leads to osteopenic states. Our current understanding of Wnt signaling in osteogenesis elucidates the molecular mechanisms of classic osteogenic pathologies. Activating and inactivating aberrations of the canonical Wnt signaling pathway in osteogenesis results in sclerosteosis and osteoporosis respectively. Recent studies have sought to target the Wnt signaling pathway to treat osteogenic disorders. Potential therapeutic approaches attempt to stimulate the Wnt signaling pathway by upregulating the intracellular mediators of the Wnt signaling cascade and inhibiting the endogenous antagonists of the pathway. Antibodies against endogenous antagonists, such as sclerostin and dickkopf-1, have demonstrated promising results in promoting bone formation and fracture healing. Lithium, an inhibitor of glycogen synthase kinase 3β, has also been reported to stimulate osteogenesis by stabilizing β catenin. Although manipulating the Wnt signaling pathway has abundant therapeutic potential, it requires cautious approach due to risks of tumorigenesis. The present review discusses the role of the Wnt signaling pathway in osteogenesis and examines its targeted therapeutic potential.